Search for a trial | Research with human participants

1 results

A randomized, double-blind, international multicenter, phase III study to evaluate the anti-tumor efficacy and safety of HLX10 (recombinant humanized anti-PD-1 monoclonal antibody injection) or placebo in combination with chemotherapy (carboplatin/cisplatin-etoposide) and concurrent radiotherapy in patients with limited-stage small cell lung cancer (LS-SCLC)

Approved WMORecruiting

This study has been transitioned to CTIS with ID 2024-515047-31-00 check the CTIS register for the current data. Primary objective:- To evaluate the anti-tumor efficacy of HLX10 in combination with chemotherapy and concurrent radiotherapy in…